[{"id":"b9fd1bb6-f212-4227-a1c0-e29d0c2b26d0","acronym":"AdeLE","url":"https://clinicaltrials.gov/study/NCT03658967","created_at":"2021-01-19T16:33:53.552Z","updated_at":"2024-07-02T16:35:32.534Z","phase":"Phase 2","brief_title":"Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE)","source_id_and_acronym":"NCT03658967 - AdeLE","lead_sponsor":"Herantis Pharma Plc.","biomarkers":" VEGFC","pipe":"","alterations":" ","tags":["VEGFC"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lymfactin (adAptVEGF-C adenoviral vector)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 06/07/2018","start_date":" 06/07/2018","primary_txt":" Primary completion: 12/16/2019","primary_completion_date":" 12/16/2019","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-10-19"}]